12:00 AM
Jan 21, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Deep TMS regulatory update

Brainsway said FDA approved Deep TMS to treat depression in patients who have failed prior therapy with antidepressants. The company said it is exploring "various...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >